Published in Gene Therapy Weekly, April 8th, 2010
"In 64 primary oral squarnous cell carcinomas (OSCCs) and 10 normal oral mucosal specimens, and in Seven human OSCC cell lines, alpha-actinin-4 expression was evaluated immunologically and correlations with clinicopathologic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.